Sartorius joins the community of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

Göttingen, Germany – January 31, 2019: Sartorius, a leading international partner of biopharmaceutical research and the industry, is pleased to announce that it has joined NIIMBL, the National Institute for Innovation in Manufacturing Biopharmaceuticals headquartered in Newark, Delaware, USA. The Institute, launched in 2017, is a public-private partnership and has an extensive network of academic and... Read more

Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) – other company programmes in AD continue

Basel, 30 January 2019 Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) – other company programmes in AD continue The Alzheimer’s Prevention Initiative (API) study of crenezumab in familial Alzheimer’s disease continues Roche remains committed to ongoing clinical studies in Alzheimer’s disease, including GRADUATE Phase... Read more

1CellBio and Partek Deliver Easy-to-use Single Cell Analysis Solution

Powerful Single Cell Bioinformatics Solution in a Graphical User Interface Powerful Single Cell Bioinformatics Solution in a Graphical User Interface ST. LOUIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–1CellBio Inc. and Partek Incorporated have partnered to deliver a data analysis pipeline for the inDrop™ System for use within Partek® Flow® bioinformatics software. The pipeline allows users to pre-process raw inDrop single cell RNA-Seq data and utilize... Read more

Shimadzu announces a New Research Facility to drive innovation further as part of the Shimadzu Technology Research Laboratory expansion.

Shimadzu Corporation has announced plans to build the SHIMADZU Future Collaboratory at the Technology Research Laboratory in Keihanna Science City, Kyoto Prefecture, Japan to expand the program of innovation at Shimadzu Corporation. The new laboratory will further drive research and development by focusing on several core themes including artificial intelligence (AI), innovative biotechnology, brain-science and... Read more

Waters Expands Accessibility to High Resolution MS Data with the First SmartMS-Enabled LC-MS Biopharma System

As the Number of Analytical Monitoring Tests for Biopharmaceuticals Skyrockets, Waters Builds Intelligence into a Fit-for-Purpose System January 22, 2019 08:30 AM Eastern Standard Time MILFORD, Mass.–(BUSINESS WIRE)–Waters Corporation (NYSE:WAT) today introduced the BioAccord™ System, a purposefully designed liquid chromatography-mass spectrometry (LC-MS) solution that will expand access to high-resolution time-of-flight mass spectrometry capabilities to more scientists.... Read more

A new tool from JEOL for structural analysis of pharmaceutical mixtures

PEABODY, MA:17 January 2019: JEOL USA has developed new methodology using the company’s ROYAL HFX Probe to offer a powerful and practical alternative for the elucidation of crucial structural information. It has particular merit in the analysis of complex pharmaceutical mixtures that contain a drug substance plus its various metabolites.  It’s a familiar challenge for... Read more

KPM Analytics expands in Asia Pacific (APAC)

Milford, MA (January 14, 2019) – To better serve distributors and customers, KPM Analytics announces their expansion in the APAC market with the addition of Patumtip “Tip” Jantarangsi as Director of Sales & Marketing, APAC. Now with four Operating Companies worldwide serving customers in the food, agriculture and environmental sectors, KPM Analytics continues to execute its growth... Read more

Merck and Roche Renew Global Distribution Agreement

DISTRIBUTION AGREEMENT ANNOUNCEMENT January 14, 2019 Merck and Roche Renew Global Distribution Agreement Global distribution agreement renewed under existing terms for additional five years Includes Biochemical Reagents and Kapa Biosystems portfolios, and select qPCR & Nucleic Acid Purification products Merck and Roche have agreed to renew their current distribution agreement for the Biochemical Reagents and... Read more

Pressure BioSciences, Inc. Announces Commercial Launch of its Unique Biopharmaceuticals Contract Services Business

January 07, 2019 Proprietary Technology Platform Offers Improved Manufacturing for Protein Therapeutic Candidates and Positions PBI to Service the $250 Billion Global Biopharmaceuticals Market SOUTH EASTON, MA / ACCESSWIRE / January 7, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale of enabling high pressure-based instruments, consumables,... Read more